Deals
Permira Said to Weigh Fresh Plans to Exit Bootmaker Dr. Martens
- Buyout firm could restart talks on sale, IPO in coming months
- Iconic footwear brand previously drew interest from Carlyle
A logo sits on the side of a Dr. Martens boot.
Photographer: Simon Dawson/Bloomberg
This article is for subscribers only.
Permira is considering reviving plans to exit its investment in iconic British bootmaker Dr. Martens, according to people familiar with the matter.
The U.K. buyout firm could restart discussions in the next few months about a potential sale or initial public offering of Dr. Martens, the people said, asking not to be identified as discussions are private.